Determinants of survival in HER2+ metastatic esophagogastric cancer. Maron SB, Chatila W, Walch H, Chou JF, et al. Clin Cancer Res 2023 Jul 5:CCR-22-3769. doi: 10.1158/1078-0432.CCR-22-3769.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maron SB, Chatila W, Walch H, Chou JF, et al. Determinants of survival in HER2+ metastatic esophagogastric cancer. Clin Cancer Res 2023 Jul 5:CCR-22-3769. doi: 10.1158/1078-0432.CCR-22-3769.
PMID: 37406106